Romero-Leguizamon C R, Ramirez-Latorre J A, Mora-Munoz L, Guerrero-Naranjo A
Universidad del Rosario. Facultad de Medicina, Bogota DC, Colombia.
Rev Neurol. 2016 Jul 1;63(1):33-41.
The signaling pathway AKT/mTOR is a central axis in regulating cellular processes, particularly in neurological diseases. In the case of epilepsy, it has been observed alteration in the pathophysiological process of the same. However, they have not described all the mechanisms of these signaling pathways that could open the opportunity to new research and therapeutic strategies.
To review existing partnerships between intracellular signaling pathways AKT and mTOR in the pathophysiology of epilepsy.
Epilepsy is a disease with a high epidemiological impact globally, so it is widely investigated regarding the pathophysiological components thereof. In that search they have been involved different intracellular signaling pathways in neurons, as determinants epileptogenic. Advances in this field have even allowed the successful implementation of new therapeutic strategies and to open the way to new research in the field.
Improving knowledge about the pathophysiological role of the signaling pathway mTOR/AKT in epilepsy can raise new investigations regarding therapeutic alternatives. The use of mTOR inhibitors, has emerged in recent years as effective in treating this disease entity alternative however is clear the necessity of continue the research for new drug therapies.
AKT/mTOR信号通路是调节细胞过程的核心轴,尤其是在神经疾病中。在癫痫方面,已观察到该信号通路的病理生理过程发生改变。然而,他们尚未描述这些信号通路的所有机制,这可能为新的研究和治疗策略带来契机。
综述细胞内信号通路AKT和mTOR在癫痫病理生理学中的现有关联。
癫痫是一种在全球具有高度流行病学影响的疾病,因此对其病理生理成分进行了广泛研究。在该研究中,不同的神经元细胞内信号通路作为致痫决定因素被涉及。该领域的进展甚至使得新治疗策略得以成功实施,并为该领域的新研究开辟了道路。
提高对mTOR/AKT信号通路在癫痫中病理生理作用的认识,可以引发关于治疗选择的新研究。近年来,mTOR抑制剂已成为治疗该疾病实体的有效替代方法,然而继续研究新的药物治疗方法显然是必要的。